Causes of Psoriasis
Psoriasis is primarily caused by a complex interplay between genetic predisposition and environmental triggers that lead to dysregulated immune responses, resulting in chronic inflammation and hyperproliferation of keratinocytes in the skin. 1
Genetic Factors
- Psoriasis has a strong genetic component with multiple susceptibility loci identified:
Immune System Dysfunction
The pathogenesis involves several key immune mechanisms:
IL-23/Th17 axis dysregulation is central to psoriasis development 1, 2
- Inappropriate activation of cutaneous T cells and dendritic cells
- Release of pro-inflammatory cytokines (TNF-α, IL-17, IL-22, IL-23)
- These cytokines create a "feed forward" inflammatory response 2
Immune cell interactions form an inflammatory loop:
- Dendritic cells produce IL-23, activating Th17 cells
- Th17 cells produce IL-17, IL-22, and other cytokines
- Keratinocytes respond by hyperproliferating and releasing more inflammatory mediators 3
- This creates a self-perpetuating cycle of inflammation
Environmental Triggers
Several environmental factors can initiate or exacerbate psoriasis in genetically predisposed individuals:
- Skin trauma (Koebner's phenomenon) 1
- Infections, particularly streptococcal infections (often triggers guttate psoriasis) 1
- Medications that can trigger or worsen psoriasis:
- Beta-blockers
- Lithium
- Antimalarials
- Interferons
- Stress - psychological stress can trigger flares 1
- Obesity - strong association with psoriasis development and severity 1
- Higher BMI correlates with increased risk
- Weight gain is a substantial risk factor for psoriasis development
Keratinocyte Abnormalities
- Hyperproliferation of epidermal keratinocytes
- Aberrant differentiation
- Shortened epidermal turnover time (3-5 days vs. normal 28-30 days)
- Keratinocytes also function as immune cells by secreting:
- Antimicrobial peptides
- Chemokines
- Pro-inflammatory cytokines 3
Clinical Implications
Understanding the multifactorial nature of psoriasis explains:
- Why treatments targeting specific immune pathways (like IL-17, IL-23, or TNF-α inhibitors) are effective
- The chronic, relapsing nature of the disease
- The association with systemic comorbidities like psoriatic arthritis, cardiovascular disease, and metabolic syndrome 1
Common Pitfalls in Understanding Psoriasis
- Misconception: Psoriasis is merely a skin disease - In reality, it's a systemic inflammatory condition with multiple comorbidities
- Misconception: Psoriasis is contagious - It is not transmissible from person to person
- Misconception: Psoriasis is solely caused by stress - While stress can trigger flares, the underlying cause is much more complex
- Misconception: Psoriasis is just cosmetic - The disease significantly impacts quality of life and is associated with serious comorbidities including cardiovascular disease and depression 1
Understanding these complex mechanisms has led to the development of targeted therapies that have revolutionized psoriasis treatment, particularly biologics targeting specific cytokines in the inflammatory cascade.